Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
4.940
-0.430 (-8.01%)
Apr 29, 2026, 1:55 PM EDT - Market open
Quantum BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 32 | 29 | 7 | 36 | 30 | 42 | |
| Market Cap Growth | 93.82% | 321.68% | -80.54% | 20.93% | -29.85% | 40.95% | |
| Enterprise Value | 29 | 30 | 0 | 32 | 6 | 3 | |
| Last Close Price | 5.37 | 7.30 | 3.68 | 59.79 | 51.25 | 66.30 | |
| PB Ratio | 6.18 | 5.76 | 0.67 | 2.77 | 0.97 | 0.78 | |
| P/TBV Ratio | 13.08 | 12.18 | 1.06 | 4.54 | 1.60 | 1.11 | |
| Debt / Equity Ratio | 0.37 | 0.37 | 0.08 | 0.03 | 0.02 | 0.01 | |
| Net Debt / Equity Ratio | -0.10 | -0.10 | -0.61 | -0.25 | -0.54 | -0.64 | |
| Net Debt / EBITDA Ratio | 0.03 | 0.03 | 0.41 | 0.19 | 0.72 | 1.17 | |
| Net Debt / FCF Ratio | 0.06 | 0.06 | 0.93 | 0.29 | 0.58 | 1.68 | |
| Quick Ratio | 0.43 | 0.43 | 1.65 | 2.39 | 2.22 | 4.13 | |
| Current Ratio | 1.07 | 1.07 | 1.81 | 2.43 | 2.28 | 5.28 | |
| Return on Equity (ROE) | -346.87% | -346.87% | -127.76% | -83.91% | -63.08% | -75.05% | |
| Return on Assets (ROA) | -67.64% | -67.64% | -58.31% | -43.02% | -33.82% | -40.20% | |
| Return on Capital Employed (ROCE) | -299.90% | -299.90% | -154.60% | -149.00% | -89.70% | -62.20% | |
| Earnings Yield | -82.99% | -89.14% | -203.95% | -50.03% | -79.79% | -83.66% | |
| FCF Yield | -26.12% | -28.05% | -98.75% | -30.26% | -96.15% | -49.19% | |
| Buyback Yield / Dilution | -189.01% | -189.01% | -86.67% | -2.21% | -10.84% | -190.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.